Writing in the CT Mirror, Dawn Hocevar, President and CEO of BioCT, urges the Connecticut legislature and Gov. Ned Lamont to take a long hard look at the drivers of prescription drug costs.
Rarely in our history has the power of science and innovation to keep our communities safe and healthy been in such clear focus.
And while vaccines have been grabbing headlines, for those of us in public health, we know that access to preventative treatments and medications is the best way to keep our population healthy and living full, productive lives.
However, far too often costs can be a significant barrier for patients when they go to the pharmacy to pick up their prescription medications …